These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Oncocognitive autoimmunity. Hall TC Cancer Chemother Rep; 1974; 58(4):441-50. PubMed ID: 4137095 [No Abstract] [Full Text] [Related]
51. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes. Umiel T; Trainin N Transplantation; 1974 Sep; 18(3):244-50. PubMed ID: 4608685 [No Abstract] [Full Text] [Related]
52. [REDUCTION OF THE PLASMA CONCENTRATION OF THE CHARLOTTE FRIEND LEUKEMOGENIC VIRUS BY ADOPTIVE IMMUNOTHERAPY (GRAFT OF ALLOGENIC BONE MARROW)]. MATHE G; AMIEL JL C R Hebd Seances Acad Sci; 1964 Dec; 259():4408-10. PubMed ID: 14256003 [No Abstract] [Full Text] [Related]
53. Immunology and immunotherapy of childhood neoplasia. Bernstein ID; Wright PW Pediatr Clin North Am; 1976 Feb; 23(1):93-109. PubMed ID: 815873 [No Abstract] [Full Text] [Related]
57. Cancer immunotherapy: facts and fancy. Benjamini E; Rennick DM CA Cancer J Clin; 1979; 29(6):362-70. PubMed ID: 116724 [No Abstract] [Full Text] [Related]
58. Immunology of breast cancer: clinical implications. Black MM Prog Clin Cancer; 1975; 6():115-37. PubMed ID: 1105675 [No Abstract] [Full Text] [Related]
59. Introduction: Immunotherapy of cancer in man, a reality. Klein E Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961 [No Abstract] [Full Text] [Related]
60. [Immunotherapy of cancer (some immunological problems in cancer therapy)]. Izumi T Bull Chest Dis Res Inst Kyoto Univ; 1973 Dec; 7(1):58-65. PubMed ID: 4135979 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]